FCFenna W. B. Craenmehr

Fenna W. B. Craenmehr

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fenna W. B. Craenmehr has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Patricia Y. W. Dankers

    Institute for Complex Molecular Systems, Eindhoven University of Technology Eindhoven The Netherlands

    2 shared publications
  • Auke A. Koops

    Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, P.O. Box 513, Eindhoven 5600 MB, The Netherlands

    1 shared publication
  • Bente A. Somsen

    Department of Biomedical Engineering and Institute for Complex Molecular Systems Laboratory of Chemical Biology Eindhoven University of Technology P.O. Box 513, MB Eindhoven 5600 Eindhoven The Netherlands

    1 shared publication
  • Christian Ottmann

    Eindhoven University of Technology

    1 shared publication
  • E. W. Meijer

    Institute for Complex Molecular Systems Eindhoven University of Technology Eindhoven 5600 MB The Netherlands

    1 shared publication
  • Emira J. Visser

    Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology

    1 shared publication

Latest Publications

  • Open Access

    Controlling Intestinal Organoid Polarity using Synthetic Dynamic Hydrogels Decorated with Laminin‐Derived IKVAV Peptides

    by Laura Rijns, Joost A. P. M. Wijnakker, Victor A. Veenbrink, Riccardo Bellan, Fenna W. B. Craenmehr, Simone I. S. Hendrikse, Johnick F. van Sprang, Wim de Lau, E. W. Meijer, Hans Clevers, et al.

    Intestinal organoids are three‐dimensional cellular structures that are cultured in laminin‐rich Matrigel, yielding organoids with correct, basal‐out polarity. Removal of Matrigel results in organoids with reversed, apical‐out polarity, demonstrating its vital role. However, Matrigel's composition is ill‐defined, and its pathogenic origin poses challenges in reproducibility. Therefore, we here introduce a fully synthetic dynamic hydrogel that presents the IKVAV peptide as a laminin‐mimic for guiding intestinal organoid polarity in a minimalistic, controlled manner. The ureido‐pyrimidinone moiety is used to form supramolecular hydrogels that have orthogonal control over properties, like stiffness, ligand type and concentration. It is found that the IKVAV peptide combined with integrin activating antibody TS2/16 controls intestinal organoid polarity. Increasing hydrogel dynamics (stress‐relaxing half‐life time of ≈1000 to 30 s) further supports the growth of intestinal organoids with correct polarity, while a bulk level of stiffness ( G ’ ≈0.7 kPa) is crucial to offer mechanical support. Through manipulation of integrins, it is revealed that the IKVAV‐organoid interaction is integrin β1‐mediated. Our findings demonstrate the essential role of the IKVAV motif in guiding intestinal organoid polarity in synthetic dynamic hydrogels – paving the way for the future design of synthetic systems to culture complex living tissue.


  • Open Access

    Controlling Drug Release From Supramolecular Polymer Surfaces by a Click‐To‐Release Reaction

    by Maritza M. Rovers, Joyce E. P. Brouns, Fenna W. B. Craenmehr, Marc Robillard, Joris W. Peeters, Henk M. Janssen, Patricia Y. W. Dankers

    Here, we introduce the combination of reactive supramolecular additives with a covalent click‐to‐release reaction. Hereto, a reactive supramolecular trans‐cyclooctene (TCO) additive is synthesized to trigger the release of a cytotoxic drug from a ureido‐pyrimidinone (UPy) based supramolecular material by soluble tetrazine (Tz) administration. Therefore, two reactive additives are designed. First, to monitor the reaction, a fluorescent UPy‐TCO‐Cy5 additive is synthesized and incorporated in a supramolecular polymer material. Reaction with Tz shows an increase in fluorescent signal in the supernatant, indicating successful release. Next, a cytotoxic UPy‐TCO‐MMC additive is synthesized and incorporated in a supramolecular polymer material where reaction with Tz results in the cell death of breast cancer cells. This study presents a new strategy for on‐demand localized drug delivery to cells from a supramolecular surface.


  • Open Access

    Functional mapping of the 14-3-3 hub protein as a guide to design 14-3-3 molecular glues

    by Bente A. Somsen, Fenna W. B. Craenmehr, Wei-Hong W. Liu, Auke A. Koops, Marloes A. M. Pennings, Emira J. Visser, Christian Ottmann, Peter J. Cossar, Luc Brunsveld

    Molecular glues represent an evolution in drug discovery, however, targeted stabilization of protein complexes remains challenging, owing to a paucity of drug design rules. The functional mapping of hotspots has been critical to protein–protein interaction (PPI) inhibitor research, however, the orthogonal approach to stabilize PPIs has not exploited this information. Utilizing the hub protein 14-3-3 as a case study we demonstrate that functional mapping of hotspots provides a triage map for 14-3-3 molecular glue development. Truncation and mutation studies allowed deconvoluting the energetic contributions of sidechain and backbone interactions of a 14-3-3-binding non-natural peptide. Three central 14-3-3 hotspots were identified and their thermodynamic characteristics profiled. In addition to the phospho-binding pocket; (i) Asn226, (ii) Lys122 and (iii) the hydrophobic patch formed by Leu218, Ile219 and Leu222 were critical for protein complex formation. Exploiting this hotspot information allowed a peptide-based molecular glue that elicits high cooperativity (α = 36) and selectively stabilizes the 14-3-3/ChREBP PPI to be uniquely developed.